Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-08-26

Clinical Trial Update: Effects of Itraconazole and Rifampin on the Blood Tazemetostat Levels [Phase 1]

View source ↗

Summary

Phase 1 trial assessing the pharmacokinetic interactions of itraconazole and rifampin with tazemetostat; results published for patients with various malignancie…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rifadin (rifampin)
  • SPORANOX (Itraconazole)
  • TAZVERIK (TAZEMETOSTAT)

Snippet

Sponsor: Epizyme, Inc. | Conditions: All Malignancies, Advanced Malignancies | Phase 1 | Status: COMPLETED | Results posted: 2024-08-26